China NMPA Product Recall - X-ray computed tomography system

Philips Medical Systems Nederland B.V., with reporting by Philips (China) Investment Co., Ltd., has issued a voluntary Level 1 recall for its Computed Tomography System (National Medical Device Registration No. 20153060422). This significant regulatory action was publicized by the National Medical Products Administration (NMPA) on June 9, 2021. The core issue involves a critical manufacturing error where incorrect fasteners were utilized during the replacement of a cooling unit (CLU), leading to the dislodgement of a CLU gantry. This defect represents a serious mechanical failure with potential for severe patient harm, thus warranting a Level 1 recall, which is reserved for situations where there is a reasonable probability of serious adverse health consequences or death. The NMPA serves as the primary regulatory body overseeing this action within China, ensuring compliance and patient safety. Philips is mandated to implement immediate and robust corrective measures to mitigate risks posed by the affected devices. Further specific details concerning the models, specifications, and batches of the impacted products are comprehensively outlined in the official 'Medical Device Recall Event Report Form.' This decisive recall highlights the manufacturer's responsibility in addressing critical product safety concerns and upholding stringent quality standards.